Status:
COMPLETED
Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments
Lead Sponsor:
AstraZeneca
Conditions:
GERD
Eligibility:
All Genders
12+ years
Brief Summary
Document how Swiss GPs allocate their GERD patients to the three GERD patient segments (according to King et al.) and how treated GERD patients are affected by their GERD treatment
Eligibility Criteria
Inclusion
- Previously diagnosed GERD patients
- on treatment for at least 2 weeks
Exclusion
- none
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2008
Estimated Enrollment :
2912 Patients enrolled
Trial Details
Trial ID
NCT00688675
Start Date
February 1 2008
End Date
August 1 2008
Last Update
December 7 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aarau, Switzerland